問題 › 取引獲得のため値引きを続けている › 会計・アドバイザリー事務所
日常的な値引きは通常、価値証明の問題とインセンティブの問題であり、料金水準の問題ではありません。 会計事務所に当てはまる問題は一般論ではありません。コンプライアンス業務の料金圧縮と法定業務を減らさずにアドバイザリーへ時間を移せない点です。82%実現率を無視した回答は誤りです。分析は売上ではなく71%の請求可能稼働率と34%のアドバイザリー成約率から始めなければなりません。
日常的な値引きは通常、価値証明の問題とインセンティブの問題であり、料金水準の問題ではありません。 会計事務所に当てはまる問題は一般論ではありません。コンプライアンス業務の料金圧縮と法定業務を減らさずにアドバイザリーへ時間を移せない点です。82%実現率を無視した回答は誤りです。分析は売上ではなく71%の請求可能稼働率と34%のアドバイザリー成約率から始めなければなりません。
値引きが常態化すると実効料金は値引き後の水準に固定され、提示料金は飾りになります。これには粗利益を超える代償があります。市場に対して実際に回収できる金額を示し、後で元に戻すのは極めて困難です。
原因は一貫しています。価値が証明されていないため料金だけが交渉変数になります。あるいはパートナーのインセンティブが粗利益ではなく請求可能時間に連動しており、値引きが合理的な行動になります。あるいは実現率の裁量が無制限で、無制限の裁量は必ず使われます。
診断は分布にあります。実現率が期末近くや特定のパートナーに集中する場合、原因はインセンティブと権限であり、料金水準ではありません。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 期末の最終週に仕掛品の評価減が進み実現率が急落します。
✓ 類似のコンプライアンス業務でパートナー間の実現率に大きな差があります。
✓ パートナーはアドバイザリー価値の証明支援ではなく評価減権限を求めます。
通常、事態を悪化させる対応です。 現実を反映して標準料金を引き下げ、基準をリセットし二四半期以内に同水準の評価減を繰り返すことです。
It is for you if you run or finance an accounting firm and discounts spike at period end. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 会計事務所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Customer Value Architecture · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 価格設定と収益最適化, one of 29 engagements the platform runs. For 会計事務所 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
裁量を上限で止め、売上ではなく粗利益で報酬を支払います。値引きは売上目標と無制限の価格権限に対する合理的な反応です。
いいえ。期間や量、紹介といった望む対価と交換する計画的なものであれば問題ありません。交渉終盤の反射的な値引きは何も得ずに利益を失う行為です。
更新時に通知と理由を付けて移行し、一部離脱を受け入れます。代替案は市場の残りがやがて知る恒常的な二重価格です。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית